Five-year trends and baseline predictors of patient-reported adverse events following breast radiotherapy with a boost in the IMPORT HIGH phase III randomised controlled trial
A systematic review and meta-analysis with focus on radiotherapy of pediatric standard-risk medulloblastoma: New strategies are needed to improve survival and reduce side-effects
Quality assurance in the randomized multicentre phase III trial EORTC-1709-BTG/CCTG CE.8 (MIRAGE) for glioblastoma: Results of the radiotherapy delineation benchmark case procedure
Effects of anatomical changes on dose and normal tissue complication probabilities and the benefit of replanning in photon and proton therapy of lung cancer patients
Predictive utility of Post-Treatment tumor apparent diffusion coefficient in High-Risk prostate cancer undergoing definitive Radiotherapy: A Long-Term outcome analysis
Gynaecological reirradiation with image-guided radiotherapy: Tumour Control Probability and Normal Tissue Complication Probability in pre-immunotherapy era☆
Towards rapid and efficient simulation-free radiotherapy: MR guided adaptive prostate radiotherapy on the MR-Linac using diagnostic MRI reference planning
Response to « Comment on ‘Local control assessment following SABR for lung metastases of colorectal cancer: A multicenter retrospective analysis‘ »
Bao Yuan Gao vs. Calendula cream for radiotherapy-induced skin toxicity in head and neck cancer: A randomized controlled trial – A biased negative trial essentially